Marquette University

e-Publications@Marquette
Biomedical Engineering Faculty Research and
Publications

Biomedical Engineering, Department of

12-2012

The Effect of Cone Opsin Mutations on Retinal Structure and the
Integrity of the Photoreceptor Mosaic
Joseph Carroll
Marquette University

Alfredo Dubra
Marquette University

Jessica C. Gardner
UCL Institute of Ophthalmology

Liliana Mizrahi-Meissonnier
Hadassah-Hebrew University Medical Center

Robert F. Cooper
Marquette University

See next page for additional authors
Follow this and additional works at: https://epublications.marquette.edu/bioengin_fac
Part of the Biomedical Engineering and Bioengineering Commons

Recommended Citation
Carroll, Joseph; Dubra, Alfredo; Gardner, Jessica C.; Mizrahi-Meissonnier, Liliana; Cooper, Robert F.; Dubis,
Adam M.; Nordgren, Rick; Genead, Mohamed; Connor, Thomas B. Jr.; Stepien, Kimberly E.; Sharon, Dror;
Hunt, David M.; Banin, Eyal; Hardcastle, Alison J.; Moore, Anthony T.; Williams, David R.; Fishman, Gerald;
Neitz, Jay; Neitz, Maureen; and Michaelides, Michel, "The Effect of Cone Opsin Mutations on Retinal
Structure and the Integrity of the Photoreceptor Mosaic" (2012). Biomedical Engineering Faculty Research
and Publications. 291.
https://epublications.marquette.edu/bioengin_fac/291

Authors
Joseph Carroll, Alfredo Dubra, Jessica C. Gardner, Liliana Mizrahi-Meissonnier, Robert F. Cooper, Adam M.
Dubis, Rick Nordgren, Mohamed Genead, Thomas B. Connor Jr., Kimberly E. Stepien, Dror Sharon, David
M. Hunt, Eyal Banin, Alison J. Hardcastle, Anthony T. Moore, David R. Williams, Gerald Fishman, Jay Neitz,
Maureen Neitz, and Michel Michaelides

This article is available at e-Publications@Marquette: https://epublications.marquette.edu/bioengin_fac/291

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

The Effect of Cone Opsin Mutations
on Retinal Structure and the
Integrity of the Photoreceptor
Mosaic
Joseph Carroll
Department of Ophthalmology
Department of Cell Biology, Neurobiology, and Anatomy
Medical College of Wisconsin
Milwaukee, WI

Alfredo Dubra
Department of Ophthalmology
Department of Biophysics, Medical College of Wisconsin,
Milwaukee, WI
Flaum Eye Institute and
Center for Visual Science, University of Rochester
Rochester, NY

Jessica C. Gardner
UCL Institute of Ophthalmology
London, United Kingdom

Liliana Mizrahi-Meissonnier
Department of Ophthalmology
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

1

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Robert F. Cooper
Department of Biomedical Engineering, Marquette University
Milwaukee, WI

Adam M. Dubis
Department of Cell Biology, Neurobiology, and Anatomy
Medical College of Wisconsin
Milwaukee, WI

Rick Nordgren
Department of Ophthalmology, Medical College of Wisconsin,
Milwaukee, WI

Mohamed Genead
Chicago Lighthouse for People Who Are Blind or Visually
Impaired, Department of Ophthalmology and Visual Sciences,
University of Illinois-Chicago
Chicago, IL

Thomas B. Connor, Jr.
Departments of Ophthalmology, Medical College of Wisconsin,
Milwaukee, WI

Kimberly E. Stepien
Departments of Ophthalmology, Medical College of Wisconsin,
Milwaukee, WI

Dror Sharon
Department of Ophthalmology, Hadassah-Hebrew University
Medical Center
Jerusalem, Israel

David M. Hunt
UCL Institute of Ophthalmology
London, United Kingdom
School of Animal Biology and Lions Eye Institute
University of Western Australia
Perth, Australia

Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

2

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Eyal Banin
Department of Ophthalmology, Hadassah-Hebrew University
Medical Center
Jerusalem, Israel

Alison J. Hardcastle
UCL Institute of Ophthalmology
London, United Kingdom

Anthony T. Moore
UCL Institute of Ophthalmology
Moorfields Eye Hospital
London, United Kingdom

David R. Williams
Flaum Eye Institute
Center for Visual Science, University of Rochester
Rochester, NY

Gerald Fishman
Chicago Lighthouse for People Who Are Blind or Visually
Impaired
Department of Ophthalmology and Visual Sciences
University of Illinois-Chicago
Chicago, IL

Jay Neitz
Department of Ophthalmology, University of Washington
Seattle, WA

Maureen Neitz
Department of Ophthalmology, University of Washington
Seattle, WA

Michel Michaelides
UCL Institute of Ophthalmology
Moorfields Eye Hospital
London, United Kingdom

Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

3

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Abstract
Purpose.
To evaluate retinal structure and photoreceptor mosaic integrity
in subjects with OPN1LW and OPN1MW mutations.

Methods.
Eleven subjects were recruited, eight of whom have been
previously described. Cone and rod density was measured using
images of the photoreceptor mosaic obtained from an adaptive optics
scanning light ophthalmoscope (AOSLO). Total retinal thickness, inner
retinal thickness, and outer nuclear layer plus Henle fiber layer
(ONL+HFL) thickness were measured using cross-sectional spectraldomain optical coherence tomography (SD-OCT) images. Molecular
genetic analyses were performed to characterize the
OPN1LW/OPN1MW gene array.

Results.
While disruptions in retinal lamination and cone mosaic
structure were observed in all subjects, genotype-specific differences
were also observed. For example, subjects with “L/M interchange”
mutations resulting from intermixing of ancestral OPN1LW and
OPN1MW genes had significant residual cone structure in the
parafovea (∼25% of normal), despite widespread retinal disruption
that included a large foveal lesion and thinning of the parafoveal inner
retina. These subjects also reported a later-onset, progressive loss of
visual function. In contrast, subjects with the C203R missense
mutation presented with congenital blue cone monochromacy, with
retinal lamination defects being restricted to the ONL+HFL and the
degree of residual cone structure (8% of normal) being consistent with
that expected for the S-cone submosaic.

Conclusions.
The photoreceptor phenotype associated with OPN1LW and
OPN1MW mutations is highly variable. These findings have implications
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for the potential restoration of visual function in subjects with opsin
mutations. Our study highlights the importance of high-resolution
phenotyping to characterize cellular structure in inherited retinal
disease; such information will be critical for selecting patients most
likely to respond to therapeutic intervention and for establishing a
baseline for evaluating treatment efficacy.

Introduction
Mutations in the long-wavelength (L) and middle-wavelength
(M) cone opsin genes (designated OPN1LW and OPN1MW,
respectively) have been associated with a wide range of visual defects
including red-green color vision deficiency, blue cone monochromacy
(BCM), X-linked cone dystrophy, X-linked cone dysfunction, and high
myopia with abnormal cone function.1–16 While characterization of
visual function in these individuals is relatively straightforward, less is
known about how the presence of OPN1LW and OPN1MW mutations
affects retinal structure. Such information will be of paramount
importance for advancing efforts to restore cone function in individuals
with OPN1LW and OPN1MW mutations.
Recent studies have shown that OPN1LW and OPN1MW
mutations resulting in congenital red-green color vision defects are
associated with a variable retinal phenotype, with some individuals
showing disrupted cone structure and/or thinning of the outer nuclear
layer (ONL).8,14,17,18 It is difficult to draw definite conclusions about the
pathogenicity of a specific mutant from comparisons of these
individuals, as there may be other factors influencing the retinal
phenotype. For example, during development, there is competition
between the first two genes in the X-chromosome opsin array in the
nascent L/M cones that ends with only one of the two genes being
expressed in each cell.19 It has been shown that the relative proportion
of cones expressing each of the two genes in the L/M array varies
widely (over 40-fold).20,21 Thus previously observed differences in
retinal phenotype may be confounded by differences in the relative
expression of the mutant opsin with respect to the normal opsin. As
the degree of retained cone photoreceptor structure is related to the
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therapeutic potential of a given retina,22 elucidation of genotypespecific retinal phenotypes is essential.
In one of the more serious vision disorders associated with
OPN1LW and OPN1MW mutations, a single type of mutant opsin is
expressed in all the cones that would have been L or M in a normal
eye. In these subjects, rods and short-wavelength (S) cones are the
only photoreceptors expressing normal photopigments. These
individuals offer the opportunity to directly evaluate the effect of
different OPN1LW and OPN1MW mutations. These mutations can be
placed into one of three categories: (1) mutations that produced
random nonhomologous missense substitutions at single amino acid
positions1,3,12,16; (2) partial or complete deletion of an exon15,23; and
(3) a recently identified category involving intermixing of ancestral
OPN1LW and OPN1MW genes to produce “L/M interchange” mutations
with deleterious combinations of nucleotides at normal polymorphic
positions.7,8,10,13 While at least one L/M interchange mutation has been
shown to directly cause cone malfunction (Greenwald SH, et al. IOVS
2012;53:ARVO E-Abstract 4643), it was recently shown that in
addition to any functional changes in the photopigment caused by the
mutations, many of the L/M interchange mutations also interfere with
recognition of exon 3 by the splicing mechanism.24 Some of the
variants incompletely interfere with splicing, so full-length mRNA is
produced as well as the inappropriately spliced transcript. Whether
there are structural differences between the mutation categories, or
for different mutations within a category, has been unknown.
Here we used adaptive optics scanning laser ophthalmoscopy
(AOSLO) and spectral-domain optical coherence tomography (SD-OCT)
to examine 11 subjects for whom all cones except the S cones express
one of six mutant opsins. There were differences in the anatomy and
in the course and severity of vision loss across mutation categories.
The subjects with L/M interchange mutations reported a later-onset
progressive loss of visual function, while those with the C203R
mutation showed a typical congenital BCM phenotype. We observed
significant disruption of retinal lamination and of cone mosaic
topography in all subjects, though the degree of disruption was
generally greater for subjects with L/M interchange mutations than for
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those with random mutations. These differences provide insight into
the underlying mechanisms responsible for loss of structure and
function in these subjects. Furthermore, while the cone loss observed
may limit success of any efforts to restore L/M cone function using
gene therapy in any of these subjects, it may be possible to develop
strategies to slow or halt the degenerative changes in people harboring
L/M interchange mutations.

Methods
Human Subjects
Written informed consent was obtained after the nature and
possible consequences of the study were explained. This study
followed the tenets of the Declaration of Helsinki and was approved by
all local ethics committees. We examined eight subjects for whom the
clinical phenotype has been previously described and three new
subjects (see Table and Supplementary Material,
http://www.iovs.org/content/53/13/8006/suppl/DC1). Two male
subjects (JC_0826, 22 years; JC_0847, 23 years) with normal color
vision were included for comparison, and data from two previously
published normative databases were used for comparison of the SDOCT studies. The data used for comparison against the horizontal line
scans consisted of 93 subjects with an average age of 25.7 ± 8.2
years,14 and the data used for comparison against the topographical
thickness maps consisted of 60 subjects with an average age of 29 ±
8.42 years.25 Axial length measurements were obtained on all subjects
(Zeiss IOL Master; Carl Zeiss Meditec, Dublin, CA) in order to
determine the scale (in microns per pixel) of each retinal image. Prior
to all retinal imaging, each eye was dilated and cycloplegia was
induced through topical application of a combination of phenylephrine
hydrochloride (2.5%) and tropicamide (1%).
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Subject

Age, Axial Length,
y
mm (OD, OS)

BCVA
L/M Array
(OD, OS) Structure

L/M
Mutation

Source*

JC_0183 16

25.65, 25.92

20/80,
20/80

0L, 1M

C203R†

Fam. C,
V:412

JC_0184 13

24.85, 24.76

20/120,
20/120

0L, 1M

C203R†

Fam. C,
V:512

JC_0440 18

25.49, 25.75

20/80,
20/80

0L, 2M

C203R† ‡

Fam. 1,
2.115

JC_0441 18

25.21, 25.12

20/80,
20/80

0L, 2M

C203R† ‡

Fam. 1,
2.215

JC_0355 31

24.54, 24.59

20/80,
20/125

1L, 1M

W177R§ ‡

IV:116

JC_0356 30

25.90, 25.88

20/125,
20/125

1L, 1M

W177R§ ‡

IV:216

JC_0347 32

24.77, 24.25

20/125,
20/125

1L, 0M

LVAVA||

This study

JC_0564 45

27.08, 26.58

20/100,
20/100

0L, 1M

LVAVA||

This study

JC_0118 32

25.83, 26.43

20/40,
20/40

1L, 0M

LIAVS||

MOL0250
III:213

KS_0577 38

23.71, 23.93

20/70,
20/100

0L, 1M

LVVVA||

This study

JC_0430 26

25.40, 25.31

20/120,
20/120

0L, 1M

Exon 2
deletion

Fam. A,
III:312

Table.

Clinical and Genetic Summary

Family.
Previous report of genotype and/or phenotype.
† Substitution of cysteine (C) for arginine (R) at position 203.
‡ Both genes in the array encode mutation.
§ Substitution of tryptophan (W) for arginine at position 177.
|| Sequence of polymorphic amino acids encoded by exon 3 of the L/M gene present in
the subjects' L/M gene array (153, 171, 174, 178, 180). L, leucine; I, isoleucine; A,
alanine; V, valine; S, serine.
Fam.,
*

Molecular Genetics
For the three newly recruited subjects, DNA was isolated from
whole blood, and the opsin genes were amplified and sequenced using
previously described methods.7
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Spectral-Domain Optical Coherence Tomography
Volumetric images of the macula were obtained using highdefinition OCT (Cirrus HD-OCT; Carl Zeiss Meditec). Volumes were
nominally 6 mm × 6 mm and consisted of 128 B-scans (512 Ascans/B-scan). Retinal thickness was calculated using the Macular
Analysis software on the Cirrus (software version 5.0; Carl Zeiss
Meditec), which is automatically determined via measurement of the
difference between the inner limiting membrane (ILM) and retinal
pigment epithelium (RPE) boundaries. High-resolution SD-OCT images
of the macula were acquired (Bioptigen, Research Triangle Park, NC).
High-density line scans (1000 A-scans/B-scan, 100 repeated B-scans)
were acquired through the foveal center, then registered and averaged
as previously described.26 No transformation (e.g., flattening),
filtering, or other postprocessing was applied to these images.
For retinal sublayer analysis, we manually segmented the ILM,
the outer plexiform layer (OPL), the external limiting membrane
(ELM), and the RPE on the high-resolution line scans as previously
described using ImageJ (National Institute of Mental Health, Bethesda,
MD).14 The ILM–RPE distance provides total retinal thickness, the ILM–
OPL distance provides the inner retinal thickness, and the OPL–ELM
distance provides the ONL plus Henle fiber layer thickness (ONL+HFL).

Adaptive Optics Retinal Imaging
An adaptive optics scanning light ophthalmoscope (AOSLO) was
used to obtain images of the photoreceptor mosaic at various retinal
locations. JC_0183, JC_0184, JC_0440, JC_0441, JC_0355, JC_0356,
JC_0118, and JC_0430 were imaged at the University of Rochester;
details of this imaging system have been previously published.27 The
remaining three subjects and the normal controls were imaged at the
Medical College of Wisconsin, and details of this system have also been
published.28 The systems derive from the basic design described by
Gray et al.,29 with the afocal telescopes folded to varying degrees.27
Both systems utilized a 97-channel deformable mirror (ALPAO, Biviers,
France) as the wavefront corrector, with a Shack-Hartman wavefront
sensor used to measure the wavefront. The imaging source was either
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a 775 nm or a 796 nm super-luminescent diode (Inphenix Inc.,
Livermore, CA), and the light exposure was kept below the safe
maximum permissible exposure set forth by ANSI.30,31 Images were
processed to remove distortions induced by the sinusoidal motion of
the resonant scanner by estimating the distortion from images of a
calibrated Ronchi ruling and then resampling the images over a grid of
equally spaced pixels. A separate calibration was done for each
subject. Images were registered to improve signal-to-noise as
previously described.32
The registered images from each subject were combined into a
single montage (Adobe Photoshop; Adobe Systems, Inc., San Jose,
CA). This montage was scaled and aligned to the LSO image from the
HD-OCT, in which a crosshair was placed at the center of the foveal
pit. The scaling was based on theoretical magnification of each system
and the alignment performed using blood vessel patterns. The
locations to be analyzed were determined based on the distance from
the center of the foveal pit, and the original image comprising that
portion of the montage was set aside for subsequent density analyses.
Cone density was measured at selected retinal locations (0.4, 0.8, 1.2,
1.6, 2.0 mm) using manual identification of cone structures (80 μm ×
80 μm sampling window). For rod analysis, we utilized a smaller
sampling window (55 μm × 55 μm) than we did for the cone density
analysis, as the cones in these subjects were more sparse and
irregularly spaced. Rod density was calculated at various locations
between 0.5 and 3 mm using a previously described semiautomated
algorithm in which the user could add/subtract missed or erroneous
cell identifications.33

Results
Different Genotype Classes Associated with Distinct
Clinical Phenotypes
The Table provides a summary of subject demographics, with
the clinical phenotype on 8 of the 11 having been reported previously.
All four subjects with C203R mutations and the subject with the exon 2
deletion presented a classical BCM phenotype, with vision based solely
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on S cones and rods.12,15 The two brothers with W177R mutations
(JC_0355 and JC_0356) had an onset in the first decade with no
history of nystagmus; both showed subsequent deterioration of visual
acuity and color vision, macular pigment epithelial disturbance, and
severe generalized cone dysfunction on ERG.16 Both had good S-cone
function with absent L/M cone function on psychophysical testing,
though the data could not entirely exclude some residual L/M cone
function in JC_0355.16
The remaining four subjects (JC_0347, JC_0564, JC_0118,
KS_0577) had OPN1LW and OPN1MW mutations that fell into the
newly discovered category involving intermixing of ancestral genes to
produce L/M interchange mutations with deleterious combinations of
nucleotides at normal polymorphic positions in exon 3.7,8,10,13,19,24 All
four of these subjects had a late-onset, progressive phenotype that
was in stark contrast to that of the subjects with a C203R mutation or
the exon 2 deletion (see Supplementary Material,
http://www.iovs.org/content/53/13/8006/suppl/DC1). While the
subjects with W177R mutations also had a progressive phenotype, it
was earlier in onset than observed for the L/M interchange mutations
and resulted in more complete loss of L/M cone function.

Reduced Retinal Thickness in Subjects with OPN1LW
and OPN1MW Mutations
Topographical maps of retinal thickness show variable but
significant macular thinning in individuals with all three classes of
mutation (see Supplementary Material and Supplementary Fig. S1,
http://www.iovs.org/content/53/13/8006/suppl/DC1). The average
(±SD) central subfield (CSF) thickness (central 1 mm) for the 11
subjects examined here was 194 ± 34 μm, compared to an average
(±SD) value for 60 normal subjects from our lab of 266 ± 19 μm; P <
0.0001, Mann-Whitney test.25 The subjects with random point
mutations had more normal CSF thickness (216 ± 20 μm) than the
individuals with L/M interchange mutations (174 ± 28 μm); P =
0.0381, Mann-Whitney test. In addition, the retinal thinning in the
subjects with L/M interchange mutations was more widespread (see
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Supplementary Material and Supplementary Fig. S1,
http://www.iovs.org/content/53/13/8006/suppl/DC1).
To investigate the reduction in retinal thickness in more detail,
we examined the thickness of the inner retina and the ONL+HFL from
high-resolution horizontal cross sections (Fig. 1), and compared it to
previously reported normative data.14 Consistent with the
topographical thickness analysis, we observed that subjects with
random point mutations had more normal total retinal thickness than
subjects in the other two genetic categories (Fig. 2A). However,
subjects with random point mutations had thinning restricted to the
ONL+HFL, while subjects with L/M interchange mutations (LVAVA,
LIAVS, and LVVVA) or the exon 2 deletion showed parafoveal thinning
of the inner retina in addition to reduced ONL+HFL thickness (Figs. 2B,
B,22C).

Figure 1.

High-resolution SD-OCT images (horizontal line scans) through the

fovea. Images are labeled with the subject ID and corresponding genotype. An image
from a normal control (JC_0847) is shown for comparison (lower right). Four layers
(labeled on the normal control scan) are associated with the hyperreflective
photoreceptor complex, with layer 1 being attributed to the ELM and layer 2 to the
ellipsoid portion of the inner segment (ISe). Layers 3 and 4 are thought to originate
from different aspects of the RPE/photoreceptor interface and RPE, respectively.34
Variable disruption of the ISe was observed across the 11 subjects. Scale bar is 200
μm.
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Figure 2.

Retinal thickness analysis along the horizontal meridian. (A)
Total retinal thickness, (B) ONL+HFL thickness, (C) inner retinal thickness.
Solid black line represents mean values for 93 normal controls, with shaded
region representing ±2 SD from the mean. Filled circles represent averaged
data for the C203R subjects (JC_0183, JC_0184, JC_0440, JC_0441); filled
triangles represent averaged data for the W177R subjects (JC_0355,
JC_0356); filled squares represent averaged data for the LVAVA subjects
(JC_0347, JC_0564); open circles represent data for the LIAVS subject
(JC_0118); open triangles represent data for the LVVVA subject (KS_0577);
and open squares represent data for the subject with the exon 2 deletion
(JC_0430). All subjects showed significant retinal thinning (total and
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ONL+HFL), with only the C203R and W177R subjects having normal inner
retinal thickness.

Variable Appearance of Outer Photoreceptor Complex
on SD-OCT in Subjects with OPN1LW and OPN1MW
Mutations
In the normal retina, at least four hyperreflective bands
comprise the outer photoreceptor complex (see JC_0847 in Fig. 1).
The innermost peak of the outer photoreceptor complex is attributed
to the ELM, while the second layer is now thought to derive from the
ellipsoid portion of the inner segment (ISe).34 The third layer is
attributed to the RPE contact cylinder, and the fourth band is
attributed to the RPE. As shown in Figure 1, we observed disruption of
the ISe in all subjects; however, there were differences between the
mutation classes that paralleled the differences in retinal thinning. Five
of the six individuals with random point mutations (JC_0183, JC_0184,
JC_0440, JC_0441, and JC_0355) had a focal disruption of the ISe
near the foveal center. In contrast, subjects with L/M interchange
mutations had generally greater disruption of the ISe: JC_0118
(LIAVS) and KS_0577 (LVVVA) had a large area of ISe loss (as did the
subject with the exon 2 deletion, JC_0430), and JC_0564 (LVAVA)
showed diffuse mottling of the ISe. However, these differences did not
segregate perfectly with genotype category, as JC_0347 (LVAVA) had
a well-defined focal lesion and JC_0356 (W177R) had diffuse mottling
of the ISe.
In the six individuals with the focal ISe disruption, the
boundaries of the disruption were marked using ImageJ35; the average
(±SD) width was 99.2 ± 43.5 μm, consistent with previous estimates
of the size of the S-cone free zone in humans.36–38

Disrupted Foveal Cone Mosaic in Subjects with OPN1LW
and OPN1MW Mutations
Foveal montages created by stitching together multiple
overlapping images are shown in Figure 3. Differences between the
genotypic categories parallel those observed in the SD-OCT images.
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We observed a hyporeflective area at or near the foveal center in the
six aforementioned subjects with a focal ISe disruption on SD-OCT,
consistent with this small area lacking healthy, waveguiding cones. A
sparse population of hyperreflective cones, presumably S cones,
surrounded this hyporeflective area. The three subjects with a larger
area of ISe loss on SD-OCT had irregular areas of hyperreflectivity in
the foveal montages with minimal cone structure present, consistent
with disruption of L, M, and S foveal cones in their macula. The
remaining two subjects had more diffuse photoreceptor mosaic
disruption across the foveal montage with only sporadic
hyperreflective cones, in keeping with the irregularly disrupted ISe.

Figure 3.

Variable disruption of the central photoreceptor mosaic. AOSLO

montages of the photoreceptor mosaic are shown, created by stitching together
multiple overlapping images. The location of the foveal pit is marked with an asterisk,
and the orientation of the montages is provided at the lower right (S, superior; I,
inferior; N, nasal; T, temporal). The location and extent of disruption visualized in the
AOSLO montages was consistent with that seen on the SD-OCT images. Scale bar is
100 μm.
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Shown in Figure 4 are plots of the putative S cones observed in
the foveal montages for the six subjects with a discrete disruption of
the ISe, compared to a plot of similar data from Curcio et al.38 While
the analysis may not capture every S cone, it does provide a robust
way to visualize the relative absence of reflective cones in a particular
region. The size of the presumed S-cone free zone, determined by
finding the largest circle that could be placed within the cone mosaic
without encroaching on any cones, ranged from 50 to 120 μm, with an
average of 72 μm for the six subjects. This is consistent with previous
estimates of the size of the S-cone free zone,36–38 providing further
support that the focal ISe represents complete loss of L/M cone
structure in the foveola. Interestingly, the center of the presumed Scone free zone did not always align to the center of the foveal pit.

Figure 4.
Visualizing the S-cone free zone. Shown are plots of putative S cones
observed in the foveal montages for the six subjects with a discrete disruption of the
ISe, compared to a plot of similar data from Curcio et al.38 Filled circles are manually
identified cones near the foveal center, identified by their bright, Gaussian reflective
profile. Open squares represent the center of the foveal pit, and it is worth noting that
the center of the presumed S-cone free zone does not always align to the center of the
foveal pit. The analysis may not capture every S cone, and thus may not provide
accurate estimates of S-cone density; however, it does provide a robust way to map
the relative absence of reflective cones in a particular region. The size of the presumed
S-cone free zone, determined by finding the largest circle that could be placed within
the cone mosaic without encroaching on any cones, ranged from 50 to 120 μm, with
an average of 72 μm for the six subjects. Scale bar is 100 μm.
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Residual Parafoveal L/M Cone Structure in Subjects
with OPN1LW and OPN1MW Mutations
The parafoveal cone mosaic in subjects with OPN1LW and
OPN1MW mutations is severely disrupted compared to normal (Fig. 5).
However, there are important differences between the genetic
categories. Between L/M interchange mutations and those with C203R
mutations and W177R mutations, the severity of the losses was
reversed compared to that in the foveal region. While the macula was
generally thinner and the foveal region more disrupted for the
interchange mutations as a group, their parafoveal cone numbers were
better preserved in the parafovea (Fig. 6). The difference was largest
at 2 mm from the fovea, the most eccentric location measured. We
were not able to resolve the rod mosaic in all subjects, but
measurements made outside the central area of ISe disruption (visible
on OCT) showed rod density consistent with that measured previously
in normals with the same technique (Fig. 7).39

Figure 5.

Disruption of the parafoveal photoreceptor mosaic. Eccentricity-

matched images from a normal (left) compared to those from four of the mutations
studied here (middle and right) are shown. The eccentricity of each image is given as
the distance from the foveal center. In the normal images, cones are the larger
structures and rods the smaller ones. In the subjects with OPN1LW and OPN1MW
mutations, there are fewer cones compared to normal and the rods appear larger, but
they still comprise a contiguous mosaic. Scale bar is 50 μm.
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Figure 6.

Genotype-dependent differences in retained cone structure. Solid

gray bars represent the minimum and maximum S-cone density values reported in a
previous histology study.38 Solid black bars represent averaged data for the C203R
subjects (JC_0183, JC_0184, JC_0440, JC_0441), while the open bars represent
averaged data for the W177R subjects (JC_0355, JC_0356). Filled squares represent
averaged data for the LVAVA subjects (JC_0347, JC_0564); open circles represent
data for the LIAVS subject (JC_0118); open triangles represent data for the LVVVA
subject (KS_0577); and the open square represents data for the subject with the exon
2 deletion (JC_0430).
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Figure 7.

Parafoveal rod density in subjects with OPN1LW and OPN1MW

mutations. It was not possible to visualize rods in all subjects or at systematic retinal
locations, but in all areas assessed (eccentric to the central ISe disruption), we
observed a contiguous rod mosaic of expected density. Subjects with C203R or W177R
are plotted as open squares; subjects with L/M interchange mutations are plotted as
filled circles; and the crosses represent normals measured using AOSLO from a
previous study.39 The solid line is the average rod density from a previous histology
report.40

Assuming a starting cone density equal to that of an average
normal,40 the residual density for the subjects with the random point
mutations was 8.5% of normal (SD = 3.0%), consistent with what
would be expected if they had only S cones remaining.37,38 In contrast,
the subjects with L/M interchange mutations had residual densities
that were on average 23% of normal (SD = 10.7%). Factoring in the
expected population of S cones, we estimate that this corresponds to a
loss of 86% of the L/M cones (SD = 9%). As normal cone density is
highly variable, it is impossible to determine the exact degree of cone
loss (or the degree of cone retention); however, it was clear that the
retinas harboring C203R or W177R had very few, if any, residual L/M
cones. Likewise, there was certainly residual L/M cone structure in
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subjects with L/M interchange mutations, consistent with the residual
L/M cone function measured with the ERG in KS_0577, JC_0347, and
JC_0564 (Kuchenbecker J, et al. IOVS 2012; 53:ARVO E-Abstract
6400). Structure/function agreement was also seen between the two
subjects with the W77R mutation; JC_0355 had higher cone density
and less retinal thinning than his brother (JC_0356), consistent with
his slightly better vision in one eye and better L/M cone function on
psychophysical testing.16

Discussion
Different Retinal Phenotypes in Subjects with OPN1LW
and OPN1MW Mutations
While all subjects had disrupted photoreceptor mosaics and
reduced retinal thickness, there were significant differences between
the mutation classes. The imaging results provide a number of insights
into the basis for the observed phenotypic differences between the
mutation categories. In general, the six subjects with random
missense mutations (C203R and W177R) had the healthiest-appearing
retinas on SD-OCT. The small disruption of the ISe that was present
was shown to correspond to the S-cone free zone,36–38 with the focal
loss of the ISe being the result of the absence of healthy L or M cones,
S cones, or rods to provide structure at the foveal center.
In contrast to the C203R and W177R mutations, the L/M
interchange mutations (four subjects) and exon 2 deletion (one
subject) appear to be more disruptive to the overall foveal
architecture. Only one of five of these subjects (JC_0347, LVAVA) had
a small focal disruption of the ISe; the others had diffuse mottling of
the ISe or a much larger absence of the ISe (extending into the
parafovea). Compared to the subjects with the random point
mutations, these subjects had greater retinal thinning that involved
the inner retina as well as the ONL. This suggests that these L/M
interchange mutations cause, or are associated with, degenerative
changes that result in damage to neighboring cells (S cones and rods)
in addition to those expressing mutant L/M opsin.
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The specificity of the photoreceptor damage to the macular
region in the subjects with L/M interchange mutations is striking when
images of the fovea are compared to more peripheral ones. Retinoid
by-products of the visual cycle and all-trans-retinal (atRAL) are
particularly toxic.41 It is possible that the cones expressing the L/M
interchange mutants remain viable through young adulthood but are
defective in their ability to participate normally in the visual cycle. This
could lead to a buildup of atRAL or other toxic retinoids, affecting not
only the cones expressing the mutant opsin, but also parafoveal S
cones and rods. If these toxic by-products are concentrated in the
fovea where the cone density is 20 times higher than in the peripheral
retina,40 it could explain why the collateral damage is higher at the
central retina compared to more eccentric locations (Fig. 1).

Implications for Restoration of Visual Function in
Subjects with OPN1LW and OPN1MW Mutations
Advances in gene therapy have generated a great deal of
excitement regarding the restoration of cone function in a variety of
retinal diseases.42–48 While subjects with L/M interchange mutations
had the greatest degree of residual parafoveal L/M cone structure, the
presence of macular atrophy and inner retinal thinning in most of
these subjects would limit the therapeutic opportunity in these
individuals at later stages of the disease. However, strategies may be
developed to slow the degenerative effects of these mutations. In
contrast, the subjects with C203R or W177R mutations generally had
more preserved retinal lamination, but adaptive optics imaging
revealed no evidence for retained L/M cone structure. It is unclear
whether any cone cell bodies remain, though given that rods appear to
have expanded to fill in the space occupied by the cones, this would
imply degeneration of at least the inner and outer segments.
We did not examine subjects with deletions involving the locus
control region (LCR), so it remains to be seen how complete absence
of L/M opsin affects cone photoreceptor integrity compared to the
expression of mutant opsin. Furthermore, we are unable to say if there
are structural differences between individuals harboring different L/M
interchange mutations. Previous evidence showed that an individual
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with the LIAVA mutant expressed by one of the two genes in the L/M
array had random, non-waveguiding cells throughout the cone mosaic,
normal ISe integrity, normal inner retinal thickness, and no change in
cone structure measured over a span of 8 years.8,18 This suggests that
the LIAVA mutant may not result in the progressive loss of L/M cones
(or does so on a much slower time scale), and it will be important to
longitudinally assess the progressive nature of the various L/M
interchange mutations to better determine the therapeutic potential in
these individuals.
In addition to using the imaging tools described here to
prioritize potential subjects most suitable for intervention, by
characterizing the degree of residual cone structure in subjects with
OPN1LW and OPN1MW mutations, it will be valuable to employ the
same techniques when evaluating the safety and efficacy of any future
therapeutic intervention. Such an approach has already been
demonstrated in patients with retinitis pigmentosa receiving ciliary
neurotrophic factor,49 where preservation of cone structure was
observed in the absence of a significant functional improvement in
vision. It is entirely plausible that structural recovery or preservation
precedes functional changes; however, this will remain unclear until
high-resolution imaging metrics become a routine part of the outcome
measures used in clinical trials.

Acknowledgments
The authors thank Pooja Godara, Zach Harvey, Jennifer Norris,
Jungtae Rha, Netta Smith, and Phyllis Summerfelt for assistance with
the study.

Footnotes
Supported by NEI Grants P30 EY001931 (JC), R01 EY017607
(JC), T32 EY014537 (AMD), UL1 RR031973 (KES, JC), R01 EY014375
(DRW), P30 EY001319 (DRW), P30 EY001730 (MN, JN), R01 EY009303
(MN), and R01 EY009620 (JN); supported by grants from the Gene
and Ruth Posner Foundation (JC), Foundation Fighting Blindness (JC,
MM), The E. Matilda Ziegler Foundation for the Blind (JC), the RD &
Linda Peters Foundation (JC), unrestricted departmental grants from
Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

22

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Research to Prevent Blindness (Medical College of Wisconsin,
University of Washington, University of Illinois-Chicago), the Juvenile
Diabetes Research Foundation (8-2002-130), Fight for Sight UK (AJH,
MM), Moorfields Eye Hospital Special Trustees (AJH, MM), and the
National Institute for Health Research Biomedical Research Centre at
Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of
Ophthalmology (AJH, ATM, MM); and supported in part by Grant No.
3000003241 from the Chief Scientist Office of the Ministry of Health,
Israel, and the Yedidut Research Grant (DS, EB). J. Carroll and A.
Dubra are recipients of Career Development Awards from Research to
Prevent Blindness. A. Dubra is the recipient of a Career Award at the
Scientific Interface from the Burroughs Wellcome Fund. M. Michaelides
is a recipient of a Career Development Award from the Foundation
Fighting Blindness. This investigation was conducted in part in a facility
constructed with support from the Research Facilities Improvement
Program; Grant C06 RR016511 from the National Center for Research
Resources, National Institutes of Health. DRW holds patents on
adaptive optics imaging.
Disclosure: J. Carroll, Imagine Eyes, Inc. (S); A. Dubra, None;
J.C. Gardner, None; L. Mizrahi-Meissonnier, None; R.F. Cooper,
None; A.M. Dubis, None; R. Nordgren, None; M. Genead, None;
T.B. Connor Jr, None; K.E. Stepien, None; D. Sharon, None; D.M.
Hunt, None; E. Banin, None; A.J. Hardcastle, None; A.T. Moore,
None; D.R. Williams, Canon (F), Polgenix (F), Pfizer (C), P,
GlaxoSmithKline (C), P, Pfizer (R); G. Fishman, None; J. Neitz,
None; M. Neitz, None; M. Michaelides, None

References
1. Nathans J, Davenport CM, Maumenee IH, et al. Molecular genetics of
human blue cone monochromacy. Science. 1989;245:831–838
2. Winderickx J, Sanocki E, Lindsey DT, et al. Defective colour vision
associated with a missense mutation in the human green visual
pigment gene. Nat Genet. 1992;1:251–256
3. Nathans J, Maumenee IA, Zrenner E, et al. Genetic heterogeneity among
blue-cone monochromats. Am J Hum Genet. 1993;53:987–1000
4. Ayyagari R, Kakuk LE, Toda Y, et al. Blue cone monochromacy: macular
degeneration in individuals with cone specific gene loss. In: Hollyfield

Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

23

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

JG, RE Anderson, LaVail MM, editors. eds Retinal Degenerative
Diseases and Experimental Therapy. New York: Kluwer
Academic/Plenum Publishers; 1999
5. Jagla WM, Jägle H, Hayashi T, et al. The molecular basis of dichromatic
color vision in males with multiple red and green visual pigment genes.
Hum Mol Genet. 2002;11:23–32
6. Kellner U, Wissinger B, Tippmann S, et al. Blue cone monochromatism:
clinical findings in patients with mutations in the red/green opsin gene
cluster. Graefes Arch Clin Exp Ophthalmol. 2004;242:729–735
7. Neitz M, Carroll J, Renner A, et al. Variety of genotypes in males diagnosed
as dichromatic on a conventional clinical anomaloscope. Vis Neurosci.
2004;21:205–216
8. Carroll J, Neitz M, Hofer H, et al. Functional photoreceptor loss revealed
with adaptive optics: an alternate cause for color blindness. Proc Natl
Acad Sci U S A. 2004;101:8461–8466
9. Young TL, Deeb SS, Ronan SM, et al. X-linked high myopia associated with
cone dysfunction. Arch Ophthalmol. 2004;122:897–908
10. Crognale MA, Fry M, Highsmith J, et al. Characterization of a novel form
of X-linked incomplete achromatopsia. Vis Neurosci. 2004;21:197–203
11. Michaelides M, Johnson S, Bradshaw K, et al. X-linked cone dysfunction
syndrome with myopia and protanopia. Ophthalmology.
2005;112:1448–1454
12. Michaelides M, Johnson S, Simunovic MP, et al. Blue cone
monochromatism: a phenotype and genotype assessment with
evidence of progressive loss of cone function in older individuals. Eye.
2005;19:2–10
13. Mizrahi-Meissonnier L, Merin S, Banin E, Sharon D. Variable retinal
phenotypes caused by mutations in the X-linked photopigment gene
array. Invest Ophthalmol Vis Sci. 2010;51:3884–3892
14. Carroll J, Baraas RC, Wagner-Schuman M, et al. Cone photoreceptor
mosaic disruption associated with Cys203Arg mutation in the M-cone
opsin. Proc Natl Acad Sci U S A. 2009;106:20948–20953
15. Gardner JC, Michaelides M, Holder GE, et al. Blue cone monochromacy:
causative mutations and associated phenotypes. Mol Vis.
2009;15:876–884
16. Gardner JC, Webb TR, Kanuga N, et al. X-linked cone dystrophy caused
by mutation of the red and green cone opsins. Am J Hum Genet.
2010;87:26–39
17. Wagner-Schuman M, Neitz J, Rha J, et al. Color-deficient cone mosaics
associated with Xq28 opsin mutations: a stop codon versus gene
deletions. Vision Res. 2010;50:2396–2402

Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

24

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

18. Rha J, Dubis AM, Wagner-Schuman M, et al. Spectral domain optical
coherence tomography and adaptive optics: imaging photoreceptor
layer morphology to interpret preclinical phenotypes. Adv Exp Med
Biol. 2010;664:309–316
19. Neitz J, Neitz M. The genetics of normal and defective color vision. Vision
Res. 2011;51:633–651
20. Carroll J, Neitz M, Neitz J. Estimates of L:M cone ratio from ERG flicker
photometry and genetics. J Vision. 2002;2:531–542
21. Hofer H, Carroll J, Neitz J, et al. Organization of the human trichromatic
cone mosaic. J Neurosci. 2005;25:9669–9679
22. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors
in blind eyes caused by RPE65 mutations: prerequisite for human gene
therapy success. Proc Natl Acad Sci U S A. 2005;102:6177–6182
23. Ladekjaer-Mikkelsen A-S, Rosenberg T, Jørgensen AL. A new mechanism
in blue cone monochromatism. Hum Genet. 1996;98:403–408
24. Ueyama H, Muraki-Oda S, Yamade S, et al. Unique haplotype in exon 3 of
cone opsin mRNA affects splicing of its precursor, leading to congenital
color vision defect. Biochem Biophys Res Commun. 2012;424:152–157
25. Wagner-Schuman M, Dubis AM, Nordgren RN, et al. Race- and sex-related
differences in retinal thickness and foveal pit morphology. Invest
Ophthalmol Vis Sci. 2010;52:625–634
26. Tanna H, Dubis AM, Ayub N, et al. Retinal imaging using commercial
broadband optical coherence tomography. Br J Ophthalmol.
2010;94:372–376
27. Dubra A, Sulai Y. Reflective afocal broadband adaptive optics scanning
ophthalmoscope. Biomed Opt Express. 2011;2:1757–1768
28. Cooper RF, Dubis AM, Pavaskar A, et al. Spatial and temporal variation of
rod photoreceptor reflectance in the human retina. Biomed Opt
Express. 2011;2:2577–2589
29. Gray DC, Merigan W, Wolfing JI, et al. In vivo fluorescence imaging of
primate retinal ganglion cells and retinal pigment epithelial cells. Opt
Express. 2006;14:7144–7158
30. ANSI American National Standard for Safe Use of Lasers (ANSI Z136.1).
ANSI Z1361-2007. The Laser Institute of America; 2007
31. Delori FC, Webb RH, Sliney DH. Institute ANS. Maximum permissible
exposures for ocular safety (ANSI 2000), with emphasis on ophthalmic
devices. J Opt Soc Am A. 2007;24:1250–1265
32. Dubra A, Harvey Z. Registration of 2D images from fast scanning
ophthalmic instruments. The 4th International Workshop on
Biomedical Image Registration. Lübeck, Germany; 2010

Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

25

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

33. Garrioch R, Langlo C, Dubis AM, et al. Repeatability of in vivo parafoveal
cone density and spacing measurements. Optom Vis Sci.
2012;89:632–643
34. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the
outer retina by optical coherence tomography: literature review and
model. Retina. 2011;31:1609–1619
35. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ.
Biophotonics Int. 2004;11:36–42
36. Williams DR, MacLeod DIA, Hayhoe MM. Punctate sensitivity of the bluesensitive mechanism. Vision Res. 1981;21:1357–1375
37. Ahnelt PK, Kolb H, Pflug R. Identification of a subtype of cone
photoreceptor, likely to be blue sensitive, in the human retina. J Comp
Neurol. 1987;255:18–34
38. Curcio CA, Allen KA, Sloan KR, et al. Distribution and morphology of
human cone photoreceptors stained with anti-blue opsin. J Comp
Neurol. 1991;312:610–624
39. Dubra A, Sulai Y, Norris JL, et al. Non-invasive imaging of the human rod
photoreceptor mosaic using a confocal adaptive optics scanning
ophthalmoscope. Biomed Opt Express. 2011;2:1864–1876
40. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor
topography. J Comp Neurol. 1990;292:497–523
41. Chen Y, Okano K, Maeda T, et al. Mechanism of all-trans-retinal toxicity
with implications for stargardt disease and age-related macular
degeneration. J Biol Chem. 2012;287:5059–5069
42. Alexander JJ, Umino Y, Everhart D, et al. Restoration of cone vision in a
mouse model of achromatopsia. Nat Med. 2007;13:685–687
43. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene
transfer for Leber's congenital amaurosis. N Engl J Med.
2008;358:2240–2248
44. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on
visual function in Leber's congenital amaurosis. N Engl J Med.
2008;358:2231–2239
45. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65
isomerase deficiency activates the retinoid cycle of vision but with slow
rod kinetics. Proc Nat Acad Sci U S A. 2008;105:15112–15117
46. Mancuso K, Hauswirth WW, Li Q, et al. Gene therapy for red-green colour
blindness in adult primates. Nature. 2009;461:784–787
47. Komáromy A, Alexander JJ, Rowlan JS, et al. Gene therapy rescues cone
function in congenital achromatopsia. Hum Mol Genet. 2010;19:2581–
2593
48. Carvalho LS, Xu J, Pearson R, et al. Long-term and age-dependent
restoration of visual function in a mouse model of CNGB3-associated

Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

26

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

achromatopsia following gene therapy. Hum Mol Genet.
2011;20:3161–3175
49. Talcott KE, Ratnam K, Sundquist S, et al. Longitudinal study of cone
photoreceptors during retinal degeneration and in response to ciliary
neurotrophic factor treatment. Invest Ophthalmol Vis Sci.
2011;52:2219–2226

Investigative Ophthalmology and Visual Science, Vol. 53, No. 13 (December 2012): pg. 8006-8015. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

27

